|
Procedure
Practice 03/15/99 - Coding
Recommendations
Feature
Article 03/15/99
Common Lung
Diseases and Disorders
Anatomy
- Respiratory
Diseases and Disorders
Diagnostic Tests - Surgical
Procedures - Coding
Tips and Guidelines
Lung disease is the number three killer in
America, responsible for one in seven deaths. More than 30
million Americans are living with chronic lung diseases such
as asthma, emphysema, or chronic bronchitis. Acute pulmonary
infections are responsible for innumerable office visits and
hospital admissions each year. This month, we review pulmonary
anatomy, discuss some common lung diagnoses, pulmonary tests,
and surgical procedures and review coding guidelines specific
to respiratory disorders.
Trachea, Bronchi, and Bronchioles
The upper structures of the respiratory system
are combined with the sensory organs of smell and taste in
the nasal cavity and mouth and the digestive system from the
oral cavity to the pharynx. At the pharynx, the specialized
respiratory organs diverge into the trachea. The trachea lies
anterior to the esophagus. The right and left main bronchi
branch off the bifurcation at the lower end of the trachea
to enter the hilus of the left or right lung. The carina is
the keel-shaped cartilage lying within the tracheal bifurcation.
The main bronchi branch off into upper, middle, and lower
lobes. These lobes continue to branch into smaller and smaller
passageways called bronchioles, forming a tree-like network
which extends throughout the spongy lung tissues. The exterior
of the bronchi is composed of elastic cartilaginous fibers
with annular reinforcements of smooth muscle that allow the
bronchi to expand and contract .
Lungs
Both lungs feature fissures that divide the
overall structures into smaller lobes. The left lung has one
horizontal fissure which divides it into two lobes (upper
and lower). The right lung has one horizontal fissure and
one oblique fissure, dividing it into three lobes (upper,
middle, and lower). It is larger than the left, extending
further down in the abdominal cavity. The entire pleural cavity
is enclosed by a serous membrane called the parietal pleura.
Each lung is surrounded by the visceral pleura. The pleural
membranes provide lubrication for the lungs as they expand
and contract. The lungs are separated by the mediastinum,
a membrane that extends from the vertebral column in back
to the sternum in front.
Alveoli and Capillary
Network
The alveoli are the functional units within
the lungs where gas exchange occurs. Each bronchiole divides
into multiple narrow inlets called alveolar ducts. The ducts
in turn subdivide and lead into three or more alveolar sacs.
Each large alveolar sac is like a grape cluster composed of
ten or more alveoli.
Two types of cells line the alveoli. Most
are flat squamous cells. A few are larger and secrete a lipid
material called surfectant. The function of surfectant
is to lower the surface tension of the molecules within the
fluid lining the alveoli, thereby facilitating respiration.
The capillary network within the alveolar
tissue allows transmission of gases between the air in the
alveoli and the blood cells within the capillaries. The tiny
capillaries allow blood cells to pass through them one at
a time. This single-file order and the delicate, semipermeable
nature of the membrane separating the alveolar sacs from the
capillaries allows the exchange of oxygen and carbon dioxide.
The blood cells passing through the capillaries are depleted
of oxygen and rich in carbon dioxide and other waste gases.
As a result, the carbon dioxide passes through the membrane
to the air within the alveoli, which is less rich in carbon
dioxide. Similarly, the oxygen within the alveoli passes through
the membrane to the blood cells. In this way, the blood gets
rid of excess carbon dioxide (which is subsequently exhaled)
and is regenerated by oxygen. The regenerated blood cells
continue on through the pulmonary vein to the heart from which
it is pumped to the rest of the body.
Diaphragm and Ribs
The diaphragm is the largest muscle of respiration,
and it is situated just below the lungs. Working with the
intercostal and abdominal muscles, the diaphragm contracts
and expands the thoracic cavity to effect respiration. The
rib cage serves as a structural support for the whole thoracic
cavity.
COPD
Chronic obstructive pulmonary disease (COPD)
includes emphysema and chronic bronchitis. Both diseases are
characterized by obstruction to airflow. Emphysema and chronic
bronchitis frequently coexist, thus physicians prefer the
term COPD. Nearly 16 million Americans suffer from COPD, which
is the fourth leading cause of death. The annual cost to the
nation for COPD is approximately $31.9 billion. Approximately
80 to 90 percent of COPD cases are caused by smoking. Other
known causes are frequent lung infections and exposure to
certain industrial pollutants.
- Emphysema
is a condition in which the alveoli become damaged and over-inflated.
Alveoli walls are thin and fragile. Damage to the walls
is irreversible and results in permanent "holes"
in the tissues of the lower lungs. As the alveoli are destroyed,
the lungs ability to transfer oxygen to the bloodstream
becomes increasingly impaired, causing shortness of breath
or "air hunger." The lungs also lose their elasticity,
making it difficult not only to inhale efficiently, but
also to exhale carbon dioxide. The bronchioles leading to
the alveoli may collapse and trap air in the lungs. This
is the condition known as emphysema.
- A1AD (Alpha-1-antitrypsin
deficiency) related emphysema is caused by
an inherited lack of a protective protein called alpha-1-antitrypsin
(AAT). In healthy individuals, AAT, which is produced in
the liver, neutralizes an enzyme called neutrophil elastase.
Neutrophil elastase is released by the white blood cells
during times of inflammation. This action is normally helpful
and is balanced by the presence of AAT. In people without
protective AAT (either because the liver does not produce
adequate amounts or cannot release it into the bloodstream),
the neutrophil elastase attacks the walls of the alveoli,
causing irreversible damage. If untreated, A1AD emphysema
is progressive and often fatal. The first signs of A1AD
related emphysema often appear between ages 30 and 40. Both
the early age at which the disease is present and the fact
that the disease most frequently appears in the lower rather
than the upper lung regions help distinguish A1AD related
emphysema from other types of emphysema.
- Chronic bronchitis
is an inflammation of the bronchial lining. When the
bronchi are inflamed and/or infected, less air flows to
and from the lungs. Chronic bronchitis is defined by the
presence of a mucus-producing cough for three months or
more for two successive years without other underlying disease
to explain the cough. It may precede or accompany pulmonary
emphysema. Cigarette smoking is the most common cause of
chronic bronchitis. Air pollution and industrial dusts and
fumes also contribute to chronic bronchitis. Once the bronchi
have been irritated over a long period of time, excessive
mucus is produced constantly, the lining of the bronchi
becomes thickened, a chronic cough develops, airflow is
hampered, and the lungs are endangered. The bronchi then
make an ideal breeding place for infections.
Asthma/Reactive Airways
Disease
About 3% of Americans have asthma. Asthma
is common in adults and even more common among children. The
American Thoracic Society defines asthma as a "disease
characterized by an increased responsiveness of the trachea
and bronchi to various stimuli
manifested by widespread
narrowing of the airways that changes in severity either spontaneously
or as a result of treatment." Asthma is characterized
by hypertrophy of the bronchial smooth muscle, mucosal edema
and hyperemia, acute inflammation, and plugging of the airways
by thick mucus. These changes result in varying degrees of
obstruction of all airways.
The pathogenesis of asthma is poorly understood.
Most researchers believe that allergic response plays a key
role in the origins of the disease and that the reversible
episodes of obstructed airflow are triggered by multiple complex
mechanisms.
Pneumothorax
Pneumothorax is the accumulation of air within
the pleural cavity. It may occur spontaneously or as the result
of trauma. Normal intrapleural air pressure is lower than
the pressure inside the lungs. This lower pressure enables
the lungs to expand during inspiration. If the lung is punctured,
air from the lung will flow out into the pleural cavity, thus
deflating the lung and making it nonfunctional. If the chest
wall is punctured and atmospheric air enters the pleural space,
again the lung will collapse as the intrapleural pressure
rises.
The development of a positive (higher than
atmospheric) pressure in the pleural cavity, called tension
pneumothorax, may accompany any type of pneumothorax. This
dangerous complication occurs if the lung is perforated in
such a way that the pleural tear acts as a one-way valve.
In this situation, air flows through the perforation into
the pleural cavity as the pleural pressure falls on inspiration.
On expiration, however, the intrapleural pressure rises and
forces the edges of the pleural tear together, trapping the
air within the pleural space. With each inspiration, more
air enters the pleural cavity but cannot escape. As the pressure
builds in the pleural cavity, the affected lung completely
collapses and the heart and mediastinum are displaced, encroaching
on the opposite pleural cavity and impairing expansion of
the opposite lung.
Atelectasis
Atelectasis refers to collapse of part of
the lung.
- Obstructive
atelectasis is caused by bronchial obstruction
such as a tumor, mucus plug, or aspirated foreign body.
- Postoperative
atelectasis is a form of obstructive atelectasis
that occurs when a patient cannot cough or breathe deeply
enough to clear respiratory secretions. The secretions accumulate
in the bronchi and prevent adequate lung expansion. Once
secretions are cleared, the lung reexpands completely.
- Compression
atelectasis is due to external compression
of the lung. The compression may be caused by the presence
of blood, fluid, or air within the pleural cavity.
Bronchiectasis
Bronchiectasis may be either a congenital
or acquired disorder of the large bronchi characterized by
abnormal dilation and destruction of the bronchial walls.
It is caused by recurrent infection and inflammation and is
primarily a disorder of childhood and adolescence. Cystic
fibrosis causes about 50% of all cases of bronchiectasis.
Bronchiolitis
This disease is an acute, often severe respiratory
illness of infants and young children under two years old.
Respiratory syncytial virus (RSV) usually causes bronchiolitis,
though other viruses and occasionally mycoplasma pneumoniae
are also sometimes responsible. Bronchiolitis is usually a
self-limited illness, but occasionally repeated infections
lead to bronchiolitis obliterans, obstruction of the bronchioles
by granulation (scar) tissue. The consequences of this condition
include dyspnea, obstructive lung disease, atelectasis, and
bronchiectasis.
Bronchiolitis Obliterans
with Organizing Pneumonia (BOOP)
This idiopathic disorder affects men and woman
equally, with most patients between the ages of 50 and 70.
In approximately one-third of all cases, the illness is preceded
by a flulike upper respiratory infection, although the precise
pathogenesis of BOOP is unknown. The disease is sometimes
associated with connective tissue disorders, cocaine use,
HIV infection, myelodysplastic syndrome, and adenovirus.
BOOP is characterized by granulation tissue
plugs within the lumens of small airways. This abnormal tissue
extends into alveolar ducts and alveoli. Additional pathologic
features include proliferation of connective tissue that forms
intramural polyps (proliferative bronchiolitis obliterans),
fibrinous exudates, and inflamed alveolar walls.
Pneumonia
Pneumonia is an inflammation of the lung characterized
by the same type of vascular changes and fluid exudate as
inflammation in other areas of the body. However, the process
is influenced by the spongy texture of the lung tissue. The
inflammatory exudate spreads unimpeded throughout the lung,
filling the alveoli, and the involved portions of lung become
relatively solid (consolidation). Pneumonia is classified
in several ways:
- Etiology - This classification
is the most important because it determines treatment. Bacteria,
viruses, or fungi may cause pneumonia. Identifying the exact
organism responsible for the disease is the key to treating
the pneumonia with effective antibiotics. Examples of organisms
responsible for pneumonia are pneumococcus, staphylococcus,
Legionella pneumophila, and pneumocystis carinii.
- Anatomic distribution of inflammation
- This classification describes whether an entire lobe of
the lung is involved (lobar pneumonia), or if inflammation
involves only those parts of the lung closest to the bronchi
(bronchopneumonia).
- Predisposing factors -
Any condition associated with poor lung ventilation and
retention of secretions predisposes an individual to pneumonia.
- Postoperative
pneumonia develops in postsurgical patients
who cannot cough or breathe deeply because of pain.
- Aspiration
pneumonia occurs when a foreign body such
as food, liquid, or vomitus is aspirated into the lungs.
- Obstructive
pneumonia occurs in the lung distal to
an area where a bronchus is narrowed or obstructed. Blockage
of a bronchus by a tumor or foreign body results in poor
aeration and retention of secretions in the obstructed
portion of the lung.
Pulmonary Tuberculosis
Pulmonary tuberculosis is transmitted via
aerosolized droplets containing the acid-fast bacterium, mycobacterium
tuberculosis. Because this bacterium is surrounded by a waxy
capsule, it is more resistant to destruction than many other
microorganisms. The body's response to the bacterium also
differs from the usual acute inflammatory reaction. The mycobacteria
are walled off by groups of monocytes and lymphocytes. The
central portion of this cellular aggregation usually becomes
necrotic. This nodular mass with central necrosis is called
a granuloma, and the inflammatory process is known as granulomatous
inflammation.
In healthy individuals with strong immune
systems, this inflammation heals by scarring. In immunocompromised
people, or in people who have inhaled a large number of organisms,
inflammation progresses and causes more extensive destruction
of lung tissue. If the granulomatous inflammatory process
makes contact with a bronchus, necrotic inflammatory tissue
is discharged into it. A cavity then forms within the lung,
surrounded by granulomatous inflammatory tissue containing
masses of the bacterium.
Respiratory Distress Syndrome
of Newborns
This condition is characterized by progressive
respiratory distress that occurs soon after birth and leads
to serious problems with oxygenation. Premature infants, Cesarean
section babies, and infants born to diabetic mothers are most
often affected. The basic cause is inadequate surfectant in
the infant's lungs. As a result, the alveoli do not expand
properly during inspiration and often collapse with expiration.
The permeability of the capillaries is also increased, allowing
fibrinogen-rich fluid to leak into the alveoli. This fluid
clots and adheres to the bronchial airways, further impeding
respiration.
Bronchopulmonary Dysplasia
Bronchopulmonary dysplasia (BPD) is a chronic
lung disease that occurs most commonly in babies who have
had respiratory problems in the first few days after birth.
BPD is seen primarily in infants born prematurely who have
required oxygen and mechanical ventilation or continuous positive
airway pressure to manage their respiratory distress. BPD
is diagnosed in infants older than four weeks who have persistent
lung disease requiring continual supplemental oxygen and who
have had abnormal chest x-rays. BPD infants often need hospitalization
for respiratory infections since their breathing status and
supplemental oxygen requirements change rapidly even with
minor infections. BPD infants often require supplemental oxygen
continuously to avoid complications of inadequate oxygen,
such as heart failure or poor growth and development.
Acute Respiratory Failure
Respiratory failure is respiratory dysfunction
resulting in decreased oxygenation (hypoxemia) or carbon dioxide
retention (hypercapnia) severe enough to threaten the function
of vital organs. Acute respiratory failure occurs in both
pulmonary and nonpulmonary diseases. Signs and symptoms of
acute respiratory failure include dyspnea, headache, cyanosis,
delirium, anxiety, hypertension, tachycardia, cardiac arrhythmias,
and tremor. Arterial blood gas criteria for acute respiratory
failure are not absolute, but in general values will indicate
hypercapnia (pCO2 over 50) and hypoxemia (pO2
of less than 60).
Interstitial Lung Disease/Pulmonary
Fibrosis
The tissue between the alveoli is referred
to as the interstitium. Interstitial Lung Disease (ILD) and
pulmonary fibrosis are general terms that include over 30
chronic lung disorders affecting the interstitium. Both terms
refer to the same range of diseases. The conditions usually
result from chronic exposure to lung irritants such as asbestos,
coal dust, grain dust, or other atmospheric pollutants. If
no cause can be found for the presence of the disease, it
is referred to as idiopathic pulmonary fibrosis. All forms
of ILD begin with an inflammatory process. The inflammation
may affect different parts of the lung: the walls of the bronchioles
(bronchiolitis), the walls of the alveoli (alveolitis), or
the capillaries of the lungs (vasculitis). Over time, the
inflamed tissues thicken and become fibrotic, making the lungs
increasingly rigid and restricting normal respiratory expansion
and contraction. The diffusion of oxygen and carbon dioxide
between the alveoli and their capillaries is impaired due
to the thickened tissue. The level of disability that a person
experiences depends on the amount of scarring.
Malignant Mesothelioma
Malignant mesotheliomas are primary tumors
arising from the surface lining of the pleura. Men with the
disease outnumber women by a 3:1 ratio. Numerous studies have
confirmed the association of malignant mesothelioma with asbestos
exposure. The disease spreads quickly along the pleural surface
and sometimes extends beyond the thoracic cavity.
Cystic Fibrosis
Cystic fibrosis (CF) is the most common fatal
genetic disease in the United States today, affecting approximately
30,000 children and young adults. One in 29 Americans is an
unknowing carrier of the defective gene.
The basic defect in CF cells is the faulty
transport of sodium and chloride (salt) within epithelial
lining of organs such as the lungs and pancreas to their outer
surfaces. CF causes the body to produce an abnormally thick,
sticky mucus. This abnormal mucus clogs the lungs and leads
to fatal infections. The thick CF mucus also obstructs the
pancreas, preventing enzymes from reaching the intestines
to digest food.
Bronchogenic Carcinomas
Lung cancer accounts for 34% of cancer deaths
in men and 21% of cancer deaths in women. Cigarette smoking
is the most important cause of lung cancer in both men and
women in the US. Other contributing factors include industrial
pollutants, radiation, including radon gas and therapeutic
radiation, asbestos, and heavy metals.
Ninety percent of malignant lung cancers belong
to one of 4 major cell types. Squamous cell carcinoma and
adenocarcinoma account for 65% of all malignant bronchogenic
neoplasms; small cell carcinoma is responsible for about 20%,
and large cell carcinoma 15%. Other malignant tumors of the
lung include adenosquamous carcinoma, carcinoid tumor, bronchial
gland carcinomas, and other rare tumors.
The clinical features of lung cancer depend
upon the cell type and location of the primary tumor, its
metastases and systemic effects. Only 10-25% of patients are
asymptomatic when initial diagnosis is made. Symptomatic lung
cancer is usually advanced and not resectable.
Pulmonary Function Tests
Pulmonary function tests (PFTs) are used to evaluate the
efficiency of ventilation and gas exchange. These tests are
helpful in determining the extent of obstructive and restrictive
lung diseases. Pulmonary ventilation is usually tested by
measuring the volume of air that can be moved in and out of
the lung under standard conditions. Two commonly used measurements
are forced vital capacity (FVC), which measures the maximum
volume of air that can be expelled after a deep inspiration;
and the one-second forced expiratory volume (FEV1),
which measures the maximum volume of air that can be expelled
in one second. Specialized tests can be done to measure the
total volume of air in the lungs and the volume of air remaining
in the lungs after maximum expiration.
Arterial Blood Gases
(ABGs)
Arterial blood gase analysis measures the concentrations
of oxygen and carbon dioxide (pO2 and pCO2)
in arterial blood in order to determine the efficiency of
gas exchange in the lungs. It is usually performed on a small
amount of blood obtained from the radial artery in the wrist.
In chronic lung disease, oxygenation of the blood is inefficient,
and arterial oxygen saturation is decreased correspondingly.
Often the arterial carbon dioxide is higher than normal because
the lungs inefficiently eliminate carbon dioxide.
Pulmonary Exercise Stress
Testing
Pulmonary stress testing is usually performed on patients
with unexplained exertional dyspnea. A bicycle ergometer or
treadmill is used and heart rate, blood pressure, respiratory
rate, oxygen saturation, and carbon dioxide ventilation are
monitored during the test.
Diagnostic Bronchoscopy
Bronchoscopy is an examination of the trachea, bronchi, and
bronchopulmonary segments. The procedure may be performed
with a rigid or flexible bronchoscope, and the entry route
may be either transoral or transnasal. The bronchoscope uses
fiber light bundles to visualize the airway and, if needed,
to obtain cytology and tissue samples for pathologic study.
Tracheostomy
This procedure is often performed when preparing a patient
for mechanical ventilatory support. A small horizontal neck
incision is made down through muscle to expose the trachea,
the trachea is then incised and an airway is inserted. A stoma
is created by suturing the skin to the tissue layers.
Surgical Bronchoscopy
Various surgical procedures may be performed through a bronchoscope.
When coding bronchoscopies, read the operative report thoroughly
to correctly identify all procedures performed.
- For bronchial biopsies,
fluoroscopy is often used to assist with navigation of the
scope's tip to the site of abnormal tissue. Closed biopsy
forceps are then passed through a channel in the scope to
obtain a tissue sample.
- Endoscopic dilation
of a stenotic portion of the trachea or bronchus may
be performed via placement of a guidewire through the bronchoscope.
The scope is then removed, and the site is dilated with
a series of dilators or stents to open the airway.
- Pulmonary abscess aspiration
may be done with passage of a needle via the scope into
abscess fluid and drainage through the needle.
- A transbronchial biopsy
is a type of bronchoscopic biopsy that involves punching
a hole through the wall of the bronchus into the lung to
obtain a lung tissue sample. Be sure to check the pathology
report whenever a bronchoscopy with biopsy is performed
to determine what type of tissue was submitted.
Thoracoscopy
Like bronchoscopy, this procedure may be diagnostic or surgical
in nature. A small incision is made between two ribs, a trocar
is passed into the thoracic cavity, and the endoscope is passed
through the trocar. The lung is usually partially collapsed
by instilling air into the chest through the trocar. The thoracic
cavity is then visualized. As with bronchoscopy, various surgical
procedures may be performed at the time of thoracoscopy, including
biopsy of the lungs or pleural tissues and removal of foreign
bodies.
Pleurodesis
Pleurodesis is performed for persistent pneumothorax and
for treatment of pleural effusions. In chemical pleurodesis
the surgeon punctures the pleural cavity with a trocar. A
catheter is advanced through the trocar into the chest. The
trocar is removed and the surgeon injects a chemical such
as tetracycline hydrochloride into the chest cavity via a
syringe attached to the outside end of the catheter. The chemical
induces adhesion between the parietal and visceral pleura.
In mechanical pleurodesis the surfaces of the visceral and
parietal pleura are abraded or roughened to form the adhesions.
Thoracentesis
This procedure removes fluid from the thoracic cavity. The
thorax is entered percutaneously via a trocar, a catheter
is introduced, and fluid is drained out of the thorax through
the catheter. It is important to note that the lung is not
punctured during thoracentesis. The outside end of the catheter
is sometimes attached to a water seal system to prevent air
from entering the thoracic cavity.
Pneumonocentesis
Pneumonocentesis is similar to thoracentesis. However, in
this procedure the trocar is passed through the visceral pleura
into the lung for drainage of a lung abscess or other fluid
collection.
Pleurectomy
A pleurectomy is performed to remove thickened pleural membrane
that prevents adequate lung expansion. The procedure is done
via an open thoracotomy or sternotomy incision. Once the thoracic
cavity is entered, the surgeon strips the constricting pleural
membrane off the lung surface, and then proceeds to strip
the parietal pleura from the inside surface of the chest cavity.
Excision-Plication/Lung Volume
Reduction
This is an open procedure to remove part of an emphysematous
lung. Access to the thoracic cavity is either via a sternal
split or transthoracic incision. The surgeon isolates the
lung tissue to be removed with sponges or staples. The diseased
tissue is excised, and the wound is closed with sutures or
wire as appropriate. A chest tube may be inserted to provide
drainage from the thoracic cavity.
Total Pneumonectomy,
Bilobectomy, Lobectomy, Segmentectomy
These terms refer to the excision of an entire lung, two
lobes, a single lobe, or part of a lobe, respectively. All
of them are open procedures done either via a vertical sternotomy
incision or horizontal transthoracic incision. A chest tube
is usually placed at closure to provide postoperative drainage.
Mechanical Ventilation
Many patients with respiratory distress syndrome or acute
respiratory failure require assisted mechanical ventilation.
A mechanical ventilator is applied with a mask covering the
nose and mouth, via oral endotracheal intubation, or via surgical
tracheostomy with intubation. Various adjustments to ventilatory
volumes and pressures enable breathing until the patient can
be weaned off the device and breathe independently.
- When coding a respiratory infection, assign a secondary
code to identify the infectious organism if known. And if
it's not easily discernible, check the lab values and culture
reports.
- When the physician documents pneumonia,
attempt to further specify the type of pneumonia as well
as the organism. If possible, avoid overuse of code 486
(pneumonia, organism unspecified). Remember that negative
culture results do not always preclude the possibility of
a bacterial infection. When in doubt, ask the attending
physician.
- Choose the code for aspiration pneumonia
based upon the type of ingestion that occurred: food or
vomitus (507.0), oil or essences (507.1), solids (non-food),
or liquids (507.8). Remember to assign two codes if both
aspiration and bacterial pneumonia are present.
- A single ICD-9-CM code (496) exists for
COPD. If COPD is documented with an additional component
condition of emphysema, chronic bronchitis, alveolitis,
asthma, or bronchiectasis, code the component condition.
- Do not assign a code for respiratory insufficiency
in the presence of COPD since it is ordinarily considered
part of the disease process.
- An acute exacerbation of chronic bronchitis
requires only one code, 491.21.
- When coding a pneumothorax, note the type
of pneumothorax. A spontaneous pneumothorax is coded as
the principal diagnosis with the underlying condition coded
as a secondary. A pneumothorax due to medical intervention
is coded to 997.3, Complications affecting body systems,
NEC, respiratory complications. A traumatic pneumothorax
requires the use of two codes: one to describe the pneumothorax,
and one to identify the wound of the specified body part.
- Bronchiolitis obliterans with organizing
pneumonia (BOOP) is coded to 516.8. If the organism is known,
remember to apply a secondary code.
- The sequencing of respiratory failure depends
upon the circumstances of the admission:
- Respiratory failure due to or associated
with a chronic, non-respiratory condition: respiratory
failure is the principal diagnosis.
- Respiratory failure due to an acute exacerbation
of a chronic, non-respiratory condition: the non-respiratory
condition is the principal diagnosis.
- Respiratory failure due to or associated
with an acute non-respiratory condition: the acute condition
is the principal diagnosis.
- Verify the type of tissue (lung or bronchus)
biopsied when coding bronchoscopy.
- Bronchoscopy with brushings and washings
is considered a biopsy in ICD-9-CM (33.24); in CPT-4 it
is considered a diagnostic procedure (31622, 31623). Be
aware of the differences between these two coding systems.
- Per the American Medical Association, when
a bronchoscopy with brushings or washings is performed with
a biopsy, assign two CPT-4 codes to correctly identify all
procedural components (31622 or 31623 AND 31625 or 31628).
- An emergency endotracheal intubation (31500)
is not a gastric tube insertion. The insertion of an endotracheal
tube and nasogastric tube is similar, but the endotracheal
tube goes to the trachea and the nasogastric tube goes to
the stomach. It can be easy to assign the wrong code unless
all documentation was carefully reviewed.
- Tracheostomies can be big DRG-boosters.
Carefully review critical care cases, particularly those
where mechanical ventilation was required, so that a tracheostomy
is not overlooked. The probability of tracheostomy increases
the longer a patient is on a ventilator.
Practice Makes Perfect!
Are you ready for some hands-on practice?
Read the patient report(s) on our procedure
practice page. Assign the appropriate codes and
then compare your answers with our coding
recommendations. Good luck!
Back to:
Top - Anatomy
- Respiratory
Diseases and Disorders
Diagnostic Tests - Surgical
Procedures - Coding
Tips and Guidelines
If you have comments or suggestions about our code selections
or about any topic on our Coding Edge® pages, please e-mail
us at codingedge@lagunamedsys.com.
|